Breast Cancer Panel tests in Dubai & UAE

Compare available Breast Cancer Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,500.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Breast Cancer Panel test prices

Showing 1–3 of 3 matching tests.

Breast Cancer Panel diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2159 Breast Comprehensive Panel Genetic Test This test evaluates 30 genes for germline variants associated with increased risk of hereditary breast, ovarian, and related cancers.	Whole Blood (EDTA), Extracted DNA, or One-Drop Blood on FTA Card	3 to 4 Weeks (Includes Confirmatory Orthogonal Validation)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic germline variants", "Hereditary cancer susceptibility"] Parameters [{"name": "Genes Analyzed", "reference_range": "30 Genes (ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2)"}] Preparation ["No fasting required", "No medication adjustments required", "Inform laboratory if patient has undergone allogeneic bone marrow transplantation", "Complete and submit clinical history form"] Indications ["Personal history of early-onset breast cancer (diagnosed before age 50)", "Personal history of triple-negative breast cancer", "Personal history of bilateral breast cancer", "Personal history of ovarian cancer at any age", "Personal history of male breast cancer", "Strong family history of breast, ovarian, pancreatic, or aggressive prostate cancer", "Ashkenazi Jewish ancestry", "Known familial pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 96783-1 ICD-10: Z15.01, Z13.820 Clinical summary This test evaluates 30 genes for germline variants associated with increased risk of hereditary breast, ovarian, and related cancers.
TEST-524 Cancer Breast Comprehensive Panel Test This diagnostic test evaluates key biomarkers in breast tissue to determine hormone receptor status, HER2 amplification, Ki-67 proliferation index, and microsatellite instability.	Archival Tissue – Formalin-fixed paraffin-embedded (FFPE) tissue block or slides	10 working days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Estrogen Receptor (ER)", "Progesterone Receptor (PR)", "HER2 Protein Expression", "HER2 Gene Amplification", "Ki-67 Proliferation Index", "Microsatellite Instability (MSI)"] Parameters [{"name": "Estrogen Receptor (ER)", "reference_range": null}, {"name": "Progesterone Receptor (PR)", "reference_range": null}, {"name": "HER2 (IHC)", "reference_range": null}, {"name": "HER2 (FISH)", "reference_range": null}, {"name": "Ki-67", "reference_range": null}, {"name": "Microsatellite Instability (MSI)", "reference_range": null}] Preparation [] Indications ["Diagnosis of breast cancer", "Prognosis assessment", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 74774-5 ICD-10: C50.9 Clinical summary This diagnostic test evaluates key biomarkers in breast tissue to determine hormone receptor status, HER2 amplification, Ki-67 proliferation index, and microsatellite instability.
TEST-2422 Expert Breast Cancer Panel Test This diagnostic test evaluates key biomarkers on breast tumour tissue to determine its subtype and guide personalised treatment.	Formalin-fixed paraffin-embedded (FFPE) tissue block, unstained slides, or cytology smears	10 working days from sample receipt	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Oestrogen Receptor (ER)", "Progesterone Receptor (PR)", "HER2/neu protein", "Ki-67 proliferation index", "Reflex markers"] Parameters [{"name": "ER (Oestrogen Receptor)", "reference_range": null}, {"name": "PR (Progesterone Receptor)", "reference_range": null}, {"name": "HER2/neu protein", "reference_range": null}, {"name": "Ki-67 proliferation index", "reference_range": null}] Preparation [] Indications ["Diagnosis of breast malignancy", "Guidance for personalised breast cancer therapy", "Assessment of treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 95941-3 ICD-10: C50.919, Z85.3, Z15.01 Clinical summary This diagnostic test evaluates key biomarkers on breast tumour tissue to determine its subtype and guide personalised treatment.

Category overview

Breast Cancer Panel: overview

Understanding your hereditary risk for breast cancer is a deeply personal, empowering step toward proactive, lifelong wellness and peace of mind. As a critical component of our specialized Molecular Diagnostics services, the comprehensive Breast Cancer Panel evaluates specific genetic mutations, including BRCA1 and BRCA2. Utilizing cutting-edge sequencing technology, this in-depth genetic screening provides the definitive clarity needed to assess your familial risk, safely guiding highly personalized preventative strategies and early medical interventions. Highly regarded for sensitive genetic testing among top diagnostic labs in the UAE, DNA Labs guarantees absolute patient confidentiality, exceptional analytical precision, and prompt, reliable turnaround times. Protect your long-term health and your family's future—schedule your breast cancer panel testing in UAE, coordinate a comfortable home sample collection, or connect with our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.